Racing for a SARS‐CoV‐2 vaccine
Graphical Abstract Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
Saved in:
| Main Authors: | Özlem Türeci, Uğur Şahin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-09-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.202115145 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India.
by: Mansi Patel, et al.
Published: (2025-03-01) -
Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic
by: Nishi Dave, et al.
Published: (2025-08-01) -
Timely development of vaccines against SARS-CoV-2
by: Shan Lu
Published: (2020-01-01) -
Prevalence of Vaccination among Patients with SARS-CoV-2
by: Falah Hasan Obayes Al-Khikani
Published: (2024-07-01) -
Pulmonary embolism after SARS-CoV-2 vaccination
by: Björn Zethelius, et al.
Published: (2024-12-01)